同伴支持辅助延长暴露疗法体内暴露作业以降低PTSD治疗脱落:随机对照试验方案
针对PTSD延长暴露(PE)治疗脱落率常超30%的问题,本随机对照试验计划纳入150名表示打算退出治疗的退伍军人,比较两种PE+同伴支持条件:同伴在体内暴露作业中直接支持3-4周,与同伴每周电话一般支持3-4周。研究假设直接作业支持可减少脱落并改善PTSD症状。
要点
- PE治疗脱落率常超过30%,同伴支持可能提高完成率。
- 试验比较同伴直接参与体内暴露作业与每周电话一般支持。
- 主要关注重返并完成治疗及PTSD症状减轻。
核心结论
- 研究拟验证同伴作为支持代理直接参与PE体内暴露作业可减少PTSD治疗脱落并减轻症状。
研究设计与样本
- 组间随机对照设计,在基线、治疗后及3、6个月随访重复评估PTSD、抑郁和功能。
- 计划纳入150名表示打算退出治疗的退伍军人。
- 参与者随机分配至两种PE+同伴支持条件之一。
- 条件1:同伴在体内暴露作业中直接提供支持3-4周。
- 条件2:同伴每周电话提供一般支持并检查治疗进展3-4周。
关键数值与推荐
- 脱落定义参照原文:患者表示打算退出治疗。
- 同伴直接支持体内暴露作业持续3-4周。
- 同伴电话一般支持每周一次持续3-4周。
- 评估时间点为基线、治疗后、3个月和6个月随访。
临床怎么用
- 若有效,可为PE治疗中打算退出的患者提供同伴直接支持体内暴露作业的辅助选项。
- 当前VA实践中的一般同伴电话支持作为对照条件。
局限性
- 原文为试验方案,尚未报告结果。
- 样本仅限退伍军人,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Effective treatments for posttraumatic stress disorder (PTSD) (e.g., prolonged exposure (PE); cognitive processing therapy (CPT)) exist and are widely adopted by the Departments of Veterans Affairs (VA) and Defense (DoD). Unfortunately, dropout from these treatments regularly exceeds 30%. However, in a recent survey of patients who dropped out of PE, approximately half indicated a greater likelihood of completion if a peer who had completed treatment were available to help with the in vivo exposure homework. METHODS: We will use a between-groups randomized controlled design with repeated assessment at baseline, post treatment, and 3- and 6-month follow-up across measures of PTSD, depression, and functioning with 150 veterans who have indicated that they intend to drop out of treatment. Participants will be randomly assigned to one of two PE + Peer Support conditions: (1) a peer will offer support directly during in vivo exposure homework for 3-4 weeks; vs (2) a peer will call weekly for 3-4 weeks to offer general support and to check in on treatment progress. DISCUSSION: The present study was designed to test the hypothesis that dropout from exposure-based PTSD treatment may be mitigated by using peers as support agents directly during PE in vivo homework experiences. Specifically, we intend to determine: whether patients who have dropped out of PE and are offered the "in vivo peer" adjunctive component to PE therapy will (1) return and complete treatment and (2) evince reduced PTSD symptomatology, compared to the same PE treatment, but with general peer support more reflective of current VA practices. TRIAL REGISTRATION: This study protocol is approved and information is available at ClinicalTrials.gov, ID: NCT03485391. Registered on 2 April 2018.
引用
- Hernandez-Tejada MA, Muzzy W, Price M, et al. Peer support during in vivo exposure homework to reverse attrition from prolonged exposure therapy for posttraumatic stress disorder (PTSD): description of a randomized controlled trial. Trials. 2020. PMID: 32345329. doi:10.1186/s13063-020-04302-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。